Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Cornips, Claire | Rägo, Lembit | Azatyan, Samvel | Laing, Richard
Affiliations: World Health Organization Collaborating Centre for Pharmacoepidemiology & Pharmaceutical Policy Analysis, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands | Quality Assurance and Safety for Medicines, Essential Medicines and Pharmaceutical Policies Department, World Health Organization, Geneva, Switzerland | Medicine Information and Evidence for Policy, Essential Medicines and Pharmaceutical Policies Department, World Health Organization, Geneva, Switzerland
Note: [] Address for correspondence: Dr Samvel Azatyan, Manager, Medicines Regulatory Support Programme, Quality Assurance and Safety: Medicines, Essential Medicines and Pharmaceutical Policies Department, World Health Organization, 20, Avenue Appia, CH-1211, Geneva 27, Switzerland. Tel.: +41 22 791 1506; Fax: +41 22 791 4167; E-mail: [email protected]
Abstract: Background: Medicines Regulatory Authorities (MRAs), among other core regulatory functions, play a vital role in stimulating the rational use of medicines by providing regulatory information of good quality to all stakeholders. Little research has attempted to report on existence and maintenance of MRA websites at global level, as well as the types of information made publicly available. Objectives: To identify functioning MRA websites on a global level, to update a study carried out in 2001 on the development of the quality and types of information of 51 websites, and to identify model components within existing websites. Methods: The Internet was searched and WHO Medicines Regional Advisers and WHO medicines country advisers (National Professional Officers) were contacted in order to identify MRA websites. The 51 websites assessed in 2001 were assessed again, using the same criteria for the quality and types of information as in 2001. Results: The number of MRA websites identified has risen from 53 to 116. Most criteria, such as frequency of updates, pharmacovigilance information and regulatory guidance for applicants for medicines marketing authorization (registration) have improved substantially. However, navigability of websites has weakened. Conclusion: Quantitative growth of the number of MRA websites is impressive. The quality of information provided on the 51 assessed websites has improved. Exemplary website components are proposed to help MRAs to improve transparency by developing and maintaining high-quality websites.
Keywords: Medicines Regulatory Authorities, websites, information, transparency
DOI: 10.3233/JRS-2010-0496
Journal: International Journal of Risk & Safety in Medicine, vol. 22, no. 2, pp. 77-88, 2010
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]